Mendenhall William M, Zlotecki Robert A, Scarborough Mark T, Gibbs C Parker, Mendenhall Nancy P
Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA.
Am J Clin Oncol. 2006 Feb;29(1):96-9. doi: 10.1097/01.coc.0000195089.11620.b7.
To discuss the treatment and outcomes for giant cell tumor (GCT) of bone.
Review of the pertinent literature.
GCT is a rare benign bone lesion most often found in the extremities of women in the third and fourth decades of life. Surgery is the mainstay of treatment and usually consists of intralesional curettage; local control rates range from 80% to 90% after this procedure. Patients with extensive, recurrent, and/or biologically more aggressive tumors may require wide excision. A small subset of patients with incompletely resectable GCTs or with lesions that are surgically inaccessible may be treated with moderate-dose radiotherapy (45-50 Gy) and have a 65% to 80% likelihood of being locally controlled.
The majority of patients with GCTs are effectively treated with intralesional curettage. Wide excision or radiotherapy is necessary to cure a relatively limited subset of patients with extensive, aggressive, and/or incompletely resectable GCTs.
探讨骨巨细胞瘤(GCT)的治疗方法及预后。
回顾相关文献。
GCT是一种罕见的良性骨病变,多见于30至40岁女性的四肢。手术是主要治疗方法,通常包括病灶内刮除术;该手术后局部控制率为80%至90%。对于肿瘤广泛、复发和/或生物学行为更具侵袭性的患者,可能需要广泛切除。一小部分GCT切除不完全或手术难以到达的患者可接受中等剂量放疗(45 - 50 Gy),局部控制的可能性为65%至80%。
大多数GCT患者通过病灶内刮除术可得到有效治疗。对于肿瘤广泛、侵袭性强和/或切除不完全的相对有限的一部分患者,需要进行广泛切除或放疗以治愈。